Masimo Corp
NASDAQ:MASI
Masimo Corp
NASDAQ:MASI
Price:
135.92 USD
-0.51%
Market Closed
Updated:
Apr 19, 2024
Masimo Corp
Operating Income
Last
Value
3-Years CAGR
5-Years CAGR
|
Masimo Corp
Operating Income Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Masimo Corp
NASDAQ:MASI
|
Operating Income
$164.3m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
6%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.4B
|
CAGR 3-Years
39%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.8B
|
CAGR 3-Years
19%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Masimo Corp's Operating Income?
Operating Income
164.3m
USD
164.3m
USD
Based on the financial report for Dec 30, 2023, Masimo Corp's Operating Income amounts to 164.3m USD.
What is Masimo Corp's Operating Income growth rate?
Operating Income CAGR 10Y
6%
6%
Over the last year, the Operating Income growth was -27%. The average annual Operating Income growth rates for Masimo Corp have been -14% over the past three years , -5% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
